Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2541221rdf:typepubmed:Citationlld:pubmed
pubmed-article:2541221lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2541221lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:2541221lifeskim:mentionsumls-concept:C0014792lld:lifeskim
pubmed-article:2541221lifeskim:mentionsumls-concept:C0079731lld:lifeskim
pubmed-article:2541221lifeskim:mentionsumls-concept:C1327616lld:lifeskim
pubmed-article:2541221lifeskim:mentionsumls-concept:C1171362lld:lifeskim
pubmed-article:2541221lifeskim:mentionsumls-concept:C0004358lld:lifeskim
pubmed-article:2541221lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:2541221lifeskim:mentionsumls-concept:C0598666lld:lifeskim
pubmed-article:2541221lifeskim:mentionsumls-concept:C1515670lld:lifeskim
pubmed-article:2541221lifeskim:mentionsumls-concept:C1521733lld:lifeskim
pubmed-article:2541221pubmed:issue5lld:pubmed
pubmed-article:2541221pubmed:dateCreated1989-6-9lld:pubmed
pubmed-article:2541221pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:abstractTextTo study the biology of cold agglutinin disease we previously established EBV-transformed B cell clones isolated from a patient with splenic lymphoma of an early plasmacytic cell type and immune hemolysis due to an anti-Pr2 cold agglutinin. These clones had an aberrant chromosomal marker identical to the patient's B cell lymphoma and each secreted IgMk anti-Pr2 similar to the pathologic autoantibody in the serum of the patient. In this study, we have further investigated the Pr2-specific autoimmune response through nucleotide sequencing of VH and VL region genes. We have shown that the seven clones share the same VDJ/VJ gene segments and junctional elements confirming their clonal origin. The VH sequences were 88% homologous to a VHI germline gene while the VL sequences were 97% homologous to a VkIII germline gene. Only 4 somatic mutations (3 silent and 1 conservative) were found in greater than 5,000 bp sequenced, suggesting that a low mutation rate existed. Based on a tumor mass of 10(12) cells and a minimum of 40 divisions, we estimated the somatic mutation rate to be 4.45 x 10(-5) m/bp/d. This somatic mutation rate is similar to those estimated for acute lymphocytic leukemia (pre-B cell) and chronic lymphocytic leukemia (intermediate B cell), but significantly lower than the mutation frequency in follicular lymphomas (activated B cell). We propose that the difference in somatic mutation frequency of a B cell tumor may be related to the stage of B cell differentiation. In addition, the low mutation frequency observed in the Pr2-specific B cell tumor may also reflect, in part, selection by autoantigen to conserve sIg structure and specificity.lld:pubmed
pubmed-article:2541221pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:languageenglld:pubmed
pubmed-article:2541221pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:citationSubsetIMlld:pubmed
pubmed-article:2541221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2541221pubmed:statusMEDLINElld:pubmed
pubmed-article:2541221pubmed:monthMaylld:pubmed
pubmed-article:2541221pubmed:issn0022-1007lld:pubmed
pubmed-article:2541221pubmed:authorpubmed-author:LitwinSSlld:pubmed
pubmed-article:2541221pubmed:authorpubmed-author:CarmackC ECElld:pubmed
pubmed-article:2541221pubmed:authorpubmed-author:SilbersteinL...lld:pubmed
pubmed-article:2541221pubmed:issnTypePrintlld:pubmed
pubmed-article:2541221pubmed:day1lld:pubmed
pubmed-article:2541221pubmed:volume169lld:pubmed
pubmed-article:2541221pubmed:ownerNLMlld:pubmed
pubmed-article:2541221pubmed:authorsCompleteYlld:pubmed
pubmed-article:2541221pubmed:pagination1631-43lld:pubmed
pubmed-article:2541221pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:2541221pubmed:meshHeadingpubmed-meshheading:2541221-...lld:pubmed
pubmed-article:2541221pubmed:meshHeadingpubmed-meshheading:2541221-...lld:pubmed
pubmed-article:2541221pubmed:meshHeadingpubmed-meshheading:2541221-...lld:pubmed
pubmed-article:2541221pubmed:meshHeadingpubmed-meshheading:2541221-...lld:pubmed
pubmed-article:2541221pubmed:meshHeadingpubmed-meshheading:2541221-...lld:pubmed
pubmed-article:2541221pubmed:meshHeadingpubmed-meshheading:2541221-...lld:pubmed
pubmed-article:2541221pubmed:meshHeadingpubmed-meshheading:2541221-...lld:pubmed
pubmed-article:2541221pubmed:meshHeadingpubmed-meshheading:2541221-...lld:pubmed
pubmed-article:2541221pubmed:meshHeadingpubmed-meshheading:2541221-...lld:pubmed
pubmed-article:2541221pubmed:meshHeadingpubmed-meshheading:2541221-...lld:pubmed
pubmed-article:2541221pubmed:meshHeadingpubmed-meshheading:2541221-...lld:pubmed
pubmed-article:2541221pubmed:meshHeadingpubmed-meshheading:2541221-...lld:pubmed
pubmed-article:2541221pubmed:meshHeadingpubmed-meshheading:2541221-...lld:pubmed
pubmed-article:2541221pubmed:meshHeadingpubmed-meshheading:2541221-...lld:pubmed
pubmed-article:2541221pubmed:meshHeadingpubmed-meshheading:2541221-...lld:pubmed
pubmed-article:2541221pubmed:meshHeadingpubmed-meshheading:2541221-...lld:pubmed
pubmed-article:2541221pubmed:meshHeadingpubmed-meshheading:2541221-...lld:pubmed
More...